|
Probiotic Effect on Hepatic Steatosis Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Probiotic Effect on Hepatic Steatosis conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Probiotic Effect on Hepatic Steatosis Clinical research trials and Probiotic Effect on Hepatic Steatosis healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Probiotic Effect on Hepatic Steatosis. Probiotic Effect on Hepatic Steatosis Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Probiotic Effect on Hepatic Steatosis clinical trial. Subjects frequently obtain the most expert healthcare possible for their Probiotic Effect on Hepatic Steatosis condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Probiotic Effect on Hepatic Steatosis  Probiotic Effect on Hepatic Steatosis
Probiotic Effect on Hepatic Steatosis
For Condition: Fatty Liver,Hepatic Steatosis
Status: Not yet recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this study is to evaluate the effect of a probiotic on hepatic steatosis. "Probiotics" are living bacteria given to improve health. "Hepatic Steatosis" is a condition of increased fat in the liver, and can lead to serious health problems in some persons.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - NAFLD (Non-alcoholic fatty liver disease) as diagnosed by liver biopsy; presumed diagnosis should also include: a. Elevated ASAT, ALT, or GGT; b. Negative Hep B & C serologies; c. Transferrin saturation <50%; d. Average daily alcohol intake of <2drinks/day. - Diagnosis of DM as determined by: a. Fasting plasma glucose >126 mg/dl or random plasma glucose of >200 mg/dl. Exclusion Criteria - Evidence of cirrhosis on liver biopsy; - Unable or unwilling to under go MR (magnetic resonance) procedures, i.e., metal fragments present, severe claustrophobia, over 350 lbs. - Patients requiring long-term antibiotic therapy for any reason; - Pregnant, planning to become pregnant, or nursing; - Unable or unwilling to provide informed consent; - Any cause of liver disease other than hepatic steatosis (e.g., hepatitis C, alcohol use).
Total Enrollment: 30
Location and Contact Information:
Overall Study Official:
AnnaDiehl, Principal Investigator, Johns Hopkins University
Johns Hopkins University
Baltimore, Maryland, 21205
United States
Steve Solga 410-502-7720
Additional Information:
Study ID Numbers: R21AT1305; Diehl
Study Start Date: October 2003
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068094
Other Fatty Liver Studies:
1. Probiotic Effect on Hepatic Steatosis
2. Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
3. Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition
4. Treatment of Nonalcoholic Steatohepatitis with Pioglitazone
Related Studies:
Other Fatty Liver Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Probiotic Effect on Hepatic Steatosis
|
|
|
|
|
|
|
|
